BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 28720048)

  • 1. Mesangial proliferative lupus nephritis with podocytopathy: a special entity of lupus nephritis.
    Wang SF; Chen YH; Chen DQ; Liu ZZ; Xu F; Zeng CH; Hu WX
    Lupus; 2018 Feb; 27(2):303-311. PubMed ID: 28720048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical-Morphological Features and Outcomes of Lupus Podocytopathy.
    Hu W; Chen Y; Wang S; Chen H; Liu Z; Zeng C; Zhang H; Liu Z
    Clin J Am Soc Nephrol; 2016 Apr; 11(4):585-92. PubMed ID: 26983707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lupus Podocytopathy: An Overview.
    Oliva-Damaso N; Payan J; Oliva-Damaso E; Pereda T; Bomback AS
    Adv Chronic Kidney Dis; 2019 Sep; 26(5):369-375. PubMed ID: 31733721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lupus podocytopathy: a distinct entity of lupus nephritis.
    Chen D; Hu W
    J Nephrol; 2018 Oct; 31(5):629-634. PubMed ID: 29270846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of glomerular podocytopathy and nephrotic proteinuria in mesangial lupus nephritis.
    Han TS; Schwartz MM; Lewis EJ
    Lupus; 2006; 15(2):71-5. PubMed ID: 16539276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid with or without additional immunosuppressant therapy for patients with lupus podocytopathy: a retrospective single-center study.
    Hu WX; Chen YH; Bao H; Liu ZZ; Wang SF; Zhang HT; Liu ZH
    Lupus; 2015 Sep; 24(10):1067-75. PubMed ID: 25819933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological features and outcomes of SLE patients with renal injury characterised by thrombotic microangiopathy.
    Chen W; Liang S; Zuo K; Yang L; Zeng C; Hu W
    Clin Rheumatol; 2021 Jul; 40(7):2735-2743. PubMed ID: 33543375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Podocyte and endothelial cell injury lead to nephrotic syndrome in proliferative lupus nephritis.
    Nawata A; Hisano S; Shimajiri S; Wang KY; Tanaka Y; Nakayama T
    Histopathology; 2018 Jun; 72(7):1084-1092. PubMed ID: 29247494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of early renal biopsy in systemic lupus erythematosus patients presenting with renal involvement.
    Hsieh YP; Wen YK; Chen ML
    Clin Nephrol; 2012 Jan; 77(1):18-24. PubMed ID: 22185964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrolimus Induction Therapy for Nephrotic Syndrome Caused by Minimal Mesangial Lupus Nephritis with Lupus Podocytopathy: A Case-Based Review.
    Kurihara I; Terai C; Yabe H; Sugawara H
    Am J Case Rep; 2022 Nov; 23():e937201. PubMed ID: 36336892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of podocyte injury with clinical features and prognosis in patients with mesangial proliferative lupus nephritis.
    Guo M; Xie X; Lin W; Zhou Y; Zhang X
    Lupus; 2023 Feb; 32(2):231-238. PubMed ID: 36459684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephrotic syndrome in mesangial proliferative lupus nephritis.
    Watanabe T
    Pediatr Int; 2007 Dec; 49(6):1009-11. PubMed ID: 18045314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collapsing glomerulopathy in 19 patients with systemic lupus erythematosus or lupus-like disease.
    Salvatore SP; Barisoni LM; Herzenberg AM; Chander PN; Nickeleit V; Seshan SV
    Clin J Am Soc Nephrol; 2012 Jun; 7(6):914-25. PubMed ID: 22461531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CMIP in podocytes is restricted to specific classes of lupus nephritis.
    Bouachi K; Moktefi A; Zhang SY; Oniszczuk J; Sendeyo K; Remy P; Audard V; Pawlak A; Ollero M; Sahali D
    PLoS One; 2018; 13(11):e0207066. PubMed ID: 30439969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesangial lupus nephritis with associated nephrotic syndrome.
    Stankeviciute N; Jao W; Bakir A; Lash JP
    J Am Soc Nephrol; 1997 Jul; 8(7):1199-204. PubMed ID: 9219171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerated recovery from nephrotic syndrome with acute renal failure by double filtration plasmapheresis in a patient with lupus podocytopathy.
    Iwazu Y; Akimoto T; Izawa S; Inoue M; Muto S; Ando Y; Iwazu K; Fukushima N; Yumura W; Kusano E
    Clin Exp Nephrol; 2012 Jun; 16(3):485-9. PubMed ID: 22350466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glomerular podocytopathy in patients with systemic lupus erythematosus.
    Kraft SW; Schwartz MM; Korbet SM; Lewis EJ
    J Am Soc Nephrol; 2005 Jan; 16(1):175-9. PubMed ID: 15548564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal biopsy findings in new-onset systemic lupus erythematosus with clinical renal disease.
    Wen YK
    Int Urol Nephrol; 2011 Sep; 43(3):801-6. PubMed ID: 21336956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of lupus nephritis: its classification and the significance of subendothelial deposits.
    Tateno S; Kobayashi Y; Shigematsu H; Hiki Y
    Q J Med; 1983; 52(207):311-31. PubMed ID: 6359226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Podocyte involvement in lupus nephritis based on the 2003 ISN/RPS system: a large cohort study from a single centre.
    Wang Y; Yu F; Song D; Wang SX; Zhao MH
    Rheumatology (Oxford); 2014 Jul; 53(7):1235-44. PubMed ID: 24599917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.